378 related articles for article (PubMed ID: 30983510)
1. Cell-free DNA diagnostics: current and emerging applications in oncology.
Muluhngwi P; Valdes R; Fernandez-Botran R; Burton E; Williams B; Linder MW
Pharmacogenomics; 2019 Apr; 20(5):357-380. PubMed ID: 30983510
[TBL] [Abstract][Full Text] [Related]
2. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients.
Sorber L; Zwaenepoel K; Deschoolmeester V; Van Schil PE; Van Meerbeeck J; Lardon F; Rolfo C; Pauwels P
Lung Cancer; 2017 May; 107():100-107. PubMed ID: 27180141
[TBL] [Abstract][Full Text] [Related]
3. Methods for Measuring ctDNA in Lymphomas.
Rossi D; Condoluci A; Spina V; Gaidano G
Methods Mol Biol; 2019; 1881():253-265. PubMed ID: 30350211
[TBL] [Abstract][Full Text] [Related]
4. A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications.
Volckmar AL; Sültmann H; Riediger A; Fioretos T; Schirmacher P; Endris V; Stenzinger A; Dietz S
Genes Chromosomes Cancer; 2018 Mar; 57(3):123-139. PubMed ID: 29205637
[TBL] [Abstract][Full Text] [Related]
5. Liquid Biopsy: Is There an Advantage to Analyzing Circulating Exosomal DNA Compared to cfDNA or Are They the Same?
Kahlert C
Cancer Res; 2019 May; 79(10):2462-2465. PubMed ID: 31043377
[TBL] [Abstract][Full Text] [Related]
6. Liquid biopsies: DNA methylation analyses in circulating cell-free DNA.
Zeng H; He B; Yi C; Peng J
J Genet Genomics; 2018 Apr; 45(4):185-192. PubMed ID: 29706556
[TBL] [Abstract][Full Text] [Related]
7. Circulating cell-free nucleic acids: characteristics and applications.
Pös O; Biró O; Szemes T; Nagy B
Eur J Hum Genet; 2018 Jul; 26(7):937-945. PubMed ID: 29681621
[TBL] [Abstract][Full Text] [Related]
8. Detection of mutational patterns in cell-free DNA of colorectal cancer by custom amplicon sequencing.
Herrmann S; Zhan T; Betge J; Rauscher B; Belle S; Gutting T; Schulte N; Jesenofsky R; Härtel N; Gaiser T; Hofheinz RD; Ebert MP; Boutros M
Mol Oncol; 2019 Aug; 13(8):1669-1683. PubMed ID: 31254442
[TBL] [Abstract][Full Text] [Related]
9. Circulating cell-free DNA for non-invasive cancer management.
Stewart CM; Tsui DWY
Cancer Genet; 2018 Dec; 228-229():169-179. PubMed ID: 29625863
[TBL] [Abstract][Full Text] [Related]
10. Potential of modern circulating cell-free DNA diagnostic tools for detection of specific tumour cells in clinical practice.
Gašperšič J; Videtič Paska A
Biochem Med (Zagreb); 2020 Oct; 30(3):030504. PubMed ID: 32774122
[TBL] [Abstract][Full Text] [Related]
11. The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients.
Zill OA; Banks KC; Fairclough SR; Mortimer SA; Vowles JV; Mokhtari R; Gandara DR; Mack PC; Odegaard JI; Nagy RJ; Baca AM; Eltoukhy H; Chudova DI; Lanman RB; Talasaz A
Clin Cancer Res; 2018 Aug; 24(15):3528-3538. PubMed ID: 29776953
[No Abstract] [Full Text] [Related]
12. An update on liquid biopsy analysis for diagnostic and monitoring applications in non-small cell lung cancer.
Mayo-de-Las-Casas C; Garzón Ibáñez M; Jordana-Ariza N; García-Peláez B; Balada-Bel A; Villatoro S; Malapelle U; Karachaliou N; Troncone G; Rosell R; Molina-Vila MA
Expert Rev Mol Diagn; 2018 Jan; 18(1):35-45. PubMed ID: 29172773
[TBL] [Abstract][Full Text] [Related]
13. Cell-Free DNA: Applications in Different Diseases.
Ranucci R
Methods Mol Biol; 2019; 1909():3-12. PubMed ID: 30580419
[TBL] [Abstract][Full Text] [Related]
14. Whole exome sequencing for determination of tumor mutation load in liquid biopsy from advanced cancer patients.
Koeppel F; Blanchard S; Jovelet C; Genin B; Marcaillou C; Martin E; Rouleau E; Solary E; Soria JC; André F; Lacroix L
PLoS One; 2017; 12(11):e0188174. PubMed ID: 29161279
[TBL] [Abstract][Full Text] [Related]
15. Bile cell‑free DNA as a novel and powerful liquid biopsy for detecting somatic variants in biliary tract cancer.
Shen N; Zhang D; Yin L; Qiu Y; Liu J; Yu W; Fu X; Zhu B; Xu X; Duan A; Chen Z; Wang X; Cao X; Zhao T; Zhou Z; Yu L; Qin H; Fang Z; Li JY; Liu Y; Xiong L; Yuan B; Li F; Zhang Y
Oncol Rep; 2019 Aug; 42(2):549-560. PubMed ID: 31173267
[TBL] [Abstract][Full Text] [Related]
16. Liquid Biopsy: Current Status and Future Perspectives.
Mader S; Pantel K
Oncol Res Treat; 2017; 40(7-8):404-408. PubMed ID: 28693023
[TBL] [Abstract][Full Text] [Related]
17. Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review).
Finotti A; Allegretti M; Gasparello J; Giacomini P; Spandidos DA; Spoto G; Gambari R
Int J Oncol; 2018 Oct; 53(4):1395-1434. PubMed ID: 30085333
[TBL] [Abstract][Full Text] [Related]
18. The liquid biopsy in the management of colorectal cancer patients: Current applications and future scenarios.
Normanno N; Cervantes A; Ciardiello F; De Luca A; Pinto C
Cancer Treat Rev; 2018 Nov; 70():1-8. PubMed ID: 30053724
[TBL] [Abstract][Full Text] [Related]
19. Liquid biopsy and its role in an advanced clinical trial for lung cancer.
Johann DJ; Steliga M; Shin IJ; Yoon D; Arnaoutakis K; Hutchins L; Liu M; Liem J; Walker K; Pereira A; Yang M; Jeffus SK; Peterson E; Xu J
Exp Biol Med (Maywood); 2018 Feb; 243(3):262-271. PubMed ID: 29405770
[TBL] [Abstract][Full Text] [Related]
20. dPCR Mutational Analyses in Cell-Free DNA: A Comparison with Tissues.
Takeshita T; Iwase H
Methods Mol Biol; 2019; 1909():105-118. PubMed ID: 30580426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
